Antithrombin drug not effective in heart failure with sinus rhythm and coronary disease
The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and ...
Aug 27, 2018
0
0